|
INTRODUCTION:
Filarial
worms
are
nematodes
that
remain
in
subcutaneous
tissues
and
lymphatics.
Eight
species
infect
human of
which 4
are
responsible
for
serious
filarial
infection.
They are
W.
bancrofti,
B.
malayi,
O.volvulus,
L. loa.
About
170
millions
are
infected
world
wide,
transmitted
by
specific
mosquitoes
or
arthropodes,
a
complex
life
cycle of
larva in
insects
and
adult
worm in
humans.
The
adult
worms
produce
microfilaria
which
vary in
size
(200 –
250
mm long and
5-7
mm
wide),
may have
loose
sheath,
when
ingested
by
insect
develop
in 1-2
weeks.
Adult
worm
survives
for many
years
but
microfilaria
survives
for 3-36
months.
A
rickettsia
like
bacteria
Wolbachia
has been
seen
intracellularly
in cases
of
Brugia,
Wuchereria,
Mansonella
and
Onchocerca.
Infection
is
established
by
repeated
exposure
to
infective
larvae.
In
natives
of
endemic
areas
the
presentation
is
chronic
debilitating
whereas
in
travelers
and
recent
exposure
it
presents
as acute
manifestation.
CHARACTERISTIC
OF
FILARIASIS
(LYMPHATICS):
|
Organism |
Periodicity |
Distribution |
Vector
(mosquito) |
Location of Adult |
Location of Microfilaria |
Sheath |
|
Wuchereria bancrofti |
Nocturnal
Subperiodic |
Worldwide South America
India
China,Indonesia
Eastern Pacific |
Culex
Anopheles
Aedes
Aedes |
Lymphatic tissue |
Blood |
+
+ |
|
Brugia malayi |
Nocturnal
Subperiodic |
India, Indonesia, Southeast Asia
Indonesia, Southeast Asia |
Mansonia, Anopheles
Mansonia, Coquillettidia |
Lymphatic tissue
Lymphatic tissue |
Blood
Blood |
+
+ |
|
Brugia timori |
Nocturnal |
Indonesia |
Anopheles |
Lymphatic Tissue |
Blood |
+ |
The
three
responsible
parasites
remain
viable
in
lymphatic
tissues
for more
than 2
decades.
EPIDEMIOLOGY:
1.
W.
bancrofti:
Widely
distributed
affecting
115
millions
, found
in
Tropics
and
subtropics.
Human is
only
definitive
host.
?
In Tropic – the microfilariae are found more at
night
(nocturnal
) than
day.
?
In subtropic specially Pacific islands –
microfilarae
are
found
throughout
the day
reaching
maximum
in
afternoon.
?
Natural Vector Culex fatigen is urban areas and
Anopheline
or
Aedian
in rural
areas.
2.
B.
malayi:
Distributed
in
India,
Indonesia,
China,
Korea,
Japan,
Philipines.
Common
nocturnal
form is
found in
coastal
rice
fields
but
Subtropical
form is
found in
forest
areas.
3.
B.
timori:
Found
only in
Indonesian
archipelago.
PATHOGENESIS
&
PATHOLOGY:
The adult worms cause inflammatory damage to lymphatics. The worm remain
in
afferent
lymphatic
or
lymphnode
sinuses
causing
lymphatic
dilatation
and
thickening.
Plasma
cell,
eosinophils,
macrophages
infiltrate
in and
around
the
infected
vessels
associated
with
endothelial
and
connective
tissue
proliferation
leading
to
lymphatic
tortuosity
and
lymphatic
valve
damage
or
incompetence.
The
overlying
skin
develops
lymphedema
and
chronics
stasis
with
hard or
brawny
oedema.
The
direct
effect
of worm
and
inflammatory
response
of host
produce
filariasis.
The
granulomatous
and
proliferative
inflammatory
response
precede
total
lymphatic
obstruction.
Lymphatic
vessels
remain
patent
till
worm is
alive.
After
death of
the worm
enhanced
granulomatous
reaction
and
fibrosis
occur.
CLINICAL
FEATURES
The
common
presentations
are
Asymptomatic
(Subclinical)
micro
filaremia,
Hydrocele,
Acute
Adenolymphangitis
(ADL),
TPE and
Chronic
manifestations.
1.
Asymptomatic
microfilaremia
– In
endemic
areas of
W.
bancrofti
and B.
malayi
though
large
number
of
microfilaria
circulate
in
peripheral
blood
many may
be
asymptomatic.
Some
present
with
microscopic
haematuria
and/or
protinuria,
dilated
or
tortous
lymphatic
and
scrotal
lymphangiectasia
(in
men).
Few
progress
to acute
or
chronic
stage.
2.
ADL –
High
fever,
lymphatic
inflammation
(lymphangitis,
lymphadenitis)
transient
local
oedema
are
presentation.
Lymphangitis
is
retrograde
from
draining
L.node
becoming
indurated
and
tender.
Lymphnode
is
enlarged.
Local
thrombophlebitis
may be
associated.
In both
bancroftian
and
brugian
variety
upper
and
lower
limbs
are
involved.
In
brugian
filariasis
local
abscess
usually
form
along
lymphatics
which
bursts
to skin.
Genitals
are
usually
affected
by
bancroftian
manifested
by
funiculitis,
epididymitis,
orchitis.
In
endemic
areas
another
acute
inflammatory
syndrome
occurs
called
dermatolymphangioadenitis
(DLA)
characterized
by high
fever,
chill,
myalgia,
headache,
edematous
inflammatory
plaques,
vesicles,
ulcers,
hyperpigmentation,
diagnosed
as
cellulites.
History
of
trauma,
burn,
radiation,
insect
bite and
chemical
injury
may be
there.
3.
Chronic
–
Progressive
lymphatic
damage
leads
from
transient
pitting
lymphedema
to
lymphatic
obstruction
and
elephantiasis
and
brawny
edema.
Thickening
of S.C.
tissues,
hyperkeratosis,
fissuring
of skin
and
hyperplastic
changes
occur,
with
superadded
infection
to these
poor
vascularized
tissues.
In
bancroftian
filariasis
involving
genitalia
leads to
hydrocele,
scrotal
lymphoedema
and
elephantiasis.
In
retroperitoneal
lymphatic
obstruction
increased
renal
lymphatic
pressure
leads to
rupture
of renal
lymphatics
producing
chyluria,
most
marked
in early
morning
urine.
Lymphedema
may be
classified:
Grade I
:
Pitting,
reversible
in
elevation
Grade
II
:
Nonpitting,
not
spontaneously
reversible
on
elevation
& loss
of
elasticity
of skin
Grade
III
:
Elephantiasis
with
skin
folds
and
pappules
4.
Manifestation
of
travelers
and
transmigrants
to
endemic
area –
After a
number
of bites
by
infected
vector
they
develop
acute
lymphangitis,
scrotal
swelling,
urticarie,
localized
angioedema.
Epitrochlear
,
axillary
,
femoral
,
inguinal
lymphadenitis
with
retrograde
lymphangitis
occur.
Classically
they are
afebrile
and
symptoms
short
lived.
5.
Tropical
pulmonary
eosinophilia
(T.P.E)
Distinct
syndrome
in some
cases of
lymphatic
filariasis
. Male
are more
effected.
Seen in
India,
Pakistan,
China,
Brazil
Pathology:
Symptoms
are due
to
allergy
and
inflammation
by lungs
which
clear
the
antigen
and
parasite.
In some
trapping
of
microfilaria
in RE
system
cause
hepatosplenomegaly
and
lymphadenopathy.
The
eosinophil
enriched
intraalveolar
infiltration
releases
cytotoxic
proinflammatory
granular
protein
which
mediate
some
pathology.
Without
successful
treatment
interstitial
fibrosis
leads to
progressive
pulmonary
damage.
Clinical
Features:
With
history
of
residing
in
endemic
area,
there is
paroxysmal
cough ,
wheeze
(nocturnal),
weight
loss,
low
grade
fever,
lymphadenopathy,
high
eosinophil
count (>
3000/ml). Chest X-ray may be normal, increased
bronchovascular
marks,
diffuse
miliary
or
mottled
opacities
in
middle
and
lower
lungs.
PFT
shows
restrictive
abnormalities
in most
and
obstructive
defect
in 50%.
Serum
IgE
raised
(10,000
to
100,000
ng/mL)
and
elevated
antifilarial
antibodies.
D/D :
Asthma,
LÖfflers
syndrome,
Allergic
bronchopulmonary
aspergillosis,
Allergic
granulomatosis
with
angitis
(Churg-Strauss
Syndrome),
Systemic
vasculitis
(Pariarteritis
nodosa,
Wegner’s
granulomatosis),
Chronic
eosinophilic
pneumonia,
Idiopathic
eosinophilic
syndrome.
H/O
exposure,
nocturnal
wheeze,
high
antibody
titre
and
response
to DEC
are
distinguished
points.
Treatment:
DEC in a
dose of
6 mg/kg
daily
for 14
days.
Relapse
may
occur in
25%
cases
requiring
retreatment.
6.
Others
rare
presentations
may be
Monoarthnitis
(knee >
Ankle),
Endomyocardial
fibrosis,
Tenosinovitis,
Thrombophlebitis
and
Nerve
Paralysis
DIAGNOSIS:
Demonstration
of
parasites
(Adult
or
microfilaria)
though
difficult
is
diagnostic.
1.
Detection
of
microfilaria
in
Blood,
hydrocele
fluid
and
other
body
fluids
under
Direct
microscopy.
For
greater
sensitivity:
i.
Filtration through a polycarbonate cylinder
(pore
size 3
mm).
ii.
Centrifuge in 2% formalin (Knott’s Technique)
?
Timing of blood collection depends on periodicity
?
DEC provocation day test – 50-100 mg of DEC
provoking
microfilaria
to
circulation
after
30-60
min.
2.
Antigen
assay –
In cases
of
cryptic
(amicrofilaremic
infections)
and
cases
where
microfilaria
not
demonstrated
it is
helpful.
For
W.
bancrofti
–
Antigen
can be
detected
by ELISA
or Rapid
format
immunochromatographic
card
test.
Both are
96-100%
sensitive
and 100%
specific.
For
B.
malayi
– No
test to
detect
antigen
3.
PCR
(Polymerase
chain
reaction)
based
assay
for DNA
of W.
bancrofti
and
B.
malayi
have
developed
which
has
greater
specificity.
4.
Detection
of adult
worm in
suspected
cases
examination
of
scrotum
and
breast
using
high
frequency
ultrasound
with
Doppler
study
may
reveal,
motile
worm in
dilated
lymphatics
(the
typical
movement
is
called
filaria
dance
sign).
5.
Radionuclide
lymphoscintigram
of
limbs-
demonstrate
widespread
lymphatic
abnormalities
both in
asymptomatic
and
clinical
cases.
6.
Supportive
diagnosis:
Eosionophilia,
elevated
serum
IgE and
antifilatrial
antibodies.
(There
is cross
reactivity
between
filarial
and
other
helminthtic
antigen
making
interpretation
a
problem.
Besides
non-infected
persons
in
endemic
areas
become
sensitized
to
filarial
antigen
by
exposure
to
infected
mosquito
bites).
DIFFERENTIAL
DIAGNOSIS:
1.
Acute
episode
–
Differentiate
from :
Thrombophlebitis,
Infection,
Trauma
2.
Chronic
filarial
lymphedema:
Differentiate
from
Malignancy,
Postoperative
scaring,
Trauma,
Chronic
oedematous
states
and
Congenital
lymphatic
system
abnormalities
TREATMENT
1.
DEC
(Diethyl
carbamazine)
6mg/kg
daily
for 12
days is
treatment
of
choice
for
active
lymphatic
filariasis
(micofilaremia,
antigen
positive,
adult
worm on
USG).
DEC is
both
macro
and
microfilaricidal.
?
Albendazole 400mg twice daily for 21 days is
also
macrofilaricidal.
2.
All
Cases
of
asymptomatic
microfilaremia
(W.
bancrifti
, B.
malayi)
should
be
treated
to
prevent
lymphatic
complications.
3.
ADL
cases
are to
be
treated
symptomatically
along
with
antibiotic.
4.
Asymptomatic
adult
worm
carriers
are to
be
treated
with
DEC.
5.
Chronic
lymphatic
manifestations
–
maintaining
hygiene,
secondary
bacterial
infection
prevention,
physiotherapy
like
other
non
filarial
lymphedema
(complex
decongestive
physiotherapy
and
complex
lymphedema
therapy)
are
accepted.
Hydrocele
needs
repeated
drainage
or
surgery.
Drug
treatment
during
active
infection
may show
clinical
improvement
and
reversal
of
lymphedema.
Some
data
indicate
that
single
dose of
DEC of
6mg/kg
or
Ivermectin
(150
mgm
/kg)or
combination
of
single
dose of
albendazole
with
DEC/Ivermectin
have
sustained
microfilaricidal
effect.
Side
effect
of DEC:
·
Fever, chill , arthralgia, headache, nausea,
vomiting.
·
Severity of symptoms are related to number of
circulating
microfilaria,
hypersensitivity
reaction
of
antigens
relased
by dead
or dying
parasite
or
inflammatory
reaction
by
lipopolysaccharides
from
intracellular
Wolbachia.
Side effects of Ivermectin - Similar to DEC
Dose 150mgm/kg
PREVENTION
&
CONTROL:
Avoidance
of
mosquito
bite:
but
using
Insect
repellent,
Mosquito
net,
Impregnated
bed
nets.
Prophylactic
use of
DEC
Community
based
intervention
like
Mass
annual
distribution
of
albendazole
with DEC
or
Ivermectin
to
suppress
microfilaria,
DEC
forfified
use and
Community
education
and
clinical
care are
helpful.
CLINICAL
FOCUS:
?
Filariasis (lymphatic) remains one of the most
common
debilitating
disease
in
trophic
&
subtropic.
?
Long life span of the adult worm and presence of
mosquito
are
responsible
for
non-eradication
from
human.
?
Microfilaria of all species are circulated in
blood
and
sheathed.
Most of
them are
nocturnal.
?
Lymphatic system is primarily involved leading
to
various
presentations.
?
Genitalia are involved by W. bancrofti.
?
TPE is a common form of inflammatory allergic
response
in
pulmonary
lymphatics.
?
Demonstration of microfilaria and adult worm is
diagnostic.
?
Newer diagnostic method like antigen assay, PCR
based
DNA
assay
are also
specific.
?
Acute and chronic filariasis are to be differentiated
from
other
common
conditions
?
DEC is the only drug of choice for acute and
chronic
cases.
Other
drugs
like
Albendazole
and
Ivermectin
alone or
in
combination
are also
micro
and
macro
filaricidal.
M.C.Q
1.
Filarial
worms
are
a. Cestodes b. Trematodes c. Nematodes d.
Protozoa
2.
Microfilaria
are
usually
a. Diurnal b. Nocturnal c. Both
d. None
of these
3.
B.timori
is found in
a. India b. China c. Korea
d.
Indonesia
4.
Local
abscess
along
lymphatic
seen in
a. Bancroftian filariasis b. Brugian
filariasis
c. Both d. None of
these
5.
Lymphedema
in
filariasis
is
a. Pitting b. Nonpitting c. Both
d. None
of these
6.
In TPE
the
Eosinophil
count is
a. >1000/ml
b.
>2000/ml c. >3000/ml
d.
<3000/ml
7.
In TPE
chest
x-ray
may show
a. Normal b. Milliary
opacities
c. Increased bronchovascular marks d. All of the above
8.
Newer
diagnostic
method
for
W.
bancrofti
are
a. Antigen detection by ELISA b. PCR based DNA assay
c. Elevated Serum IgE d. All of the above
9.
Drugs
used for
lymphatic
filariasis
a. DEC b. Albendazole c. Ivermectin
d. Any
of the
above
10.
Side
effects
during
treatment
are due
to
a. Hypersensitivity reaction to released antigen b. Inflammatory
reaction
by
Wolbachia
c. Gastric irritation
d. All
of the
above
ANSWER
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
|
C |
B |
D |
B |
C |
C |
D |
D |
D |
D |
|